Matthew G.  Manders net worth and biography

Matthew Manders Biography and Net Worth

Insider of Cigna Group
Matthew G. Manders has been appointed as President - Government and Solutions of the Company effective 01/01/2021. He served as Cigna’s President, Strategy and Solutions beginning November 2018; President, Government & Individual Programs and Group Insurance from February 2017 through November 2017; President, U.S. Markets from June 2014 until February 2017; President, Regional and Operations from November 2011 until June 2014; President, U.S. Service, Clinical and Specialty from January 2010 until November 2011; and President, Cigna HealthCare, Total Health, Productivity, Network & Middle Market from June 2009 until January 2010.

What is Matthew G. Manders' net worth?

The estimated net worth of Matthew G. Manders is at least $13.62 million as of March 1st, 2021. Mr. Manders owns 50,998 shares of Cigna Group stock worth more than $13,621,617 as of December 4th. This net worth evaluation does not reflect any other investments that Mr. Manders may own. Learn More about Matthew G. Manders' net worth.

How do I contact Matthew G. Manders?

The corporate mailing address for Mr. Manders and other Cigna Group executives is 900 COTTAGE GROVE ROAD, BLOOMFIELD CT, 06002. Cigna Group can also be reached via phone at (860) 226-6000 and via email at [email protected]. Learn More on Matthew G. Manders' contact information.

Has Matthew G. Manders been buying or selling shares of Cigna Group?

Matthew G. Manders has not been actively trading shares of Cigna Group in the last ninety days. Most recently, Matthew G. Manders sold 3,087 shares of the business's stock in a transaction on Monday, March 1st. The shares were sold at an average price of $212.37, for a transaction totalling $655,586.19. Following the completion of the sale, the insider now directly owns 50,998 shares of the company's stock, valued at $10,830,445.26. Learn More on Matthew G. Manders' trading history.

Who are Cigna Group's active insiders?

Cigna Group's insider roster includes Mary Agolglia Hoeltzel (VP), Lisa Bacus (EVP), David Cordani (President, CEO & Chairman of the Board), William DeLaney, III (Director), Noelle Eder (EVP and Global Chief Information Officer), Brian Evanko (CFO), Brian Evanko (Exec. VP & CFO ), Eric Foss (Director), Elder Granger (Director), Isaiah Harris, Jr. (Chairman), Mary Hoeltzel (CAO), Nicole Jones (EVP), Matthew Manders (Insider), Thomas McCarthy (CFO), Steven Miller (EVP), Alan Muney (EVP), John Murabito (EVP), Everett Neville (EVP), Eric Palmer (CFO), John Partridge (Director), William Roper (Director), Cynthia Ryan (EVP), Jason Sadler (President, International Health), Paul Sanford (EVP), Michael Triplett (Insider), Timothy Wentworth (CEO), and Donna Zarcone (Director). Learn More on Cigna Group's active insiders.

Are insiders buying or selling shares of Cigna Group?

During the last year, Cigna Group insiders bought shares 1 times. They purchased a total of 4,134 shares worth more than $999,931.92. During the last year, insiders at the health services provider sold shares 6 times. They sold a total of 77,645 shares worth more than $23,772,191.32. The most recent insider tranaction occured on November, 3rd when CEO David Cordani bought 4,134 shares worth more than $999,931.92. Insiders at Cigna Group own 0.7% of the company. Learn More about insider trades at Cigna Group.

Information on this page was last updated on 11/3/2025.

Matthew G. Manders Insider Trading History at Cigna Group

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/1/2021Sell3,087$212.37$655,586.1950,998View SEC Filing Icon  
1/21/2021Sell5,596$230.06$1,287,415.7640,422View SEC Filing Icon  
3/2/2020Sell3,969$182.85$725,731.6546,018View SEC Filing Icon  
7/21/2017Sell24,357$175.01$4,262,718.5746,256View SEC Filing Icon  
6/2/2017Sell6,000$165.00$990,000.0033,799View SEC Filing Icon  
2/27/2017Sell8,309$146.54$1,217,600.8639,799View SEC Filing Icon  
6/12/2013Sell36,868$68.75$2,534,675.00View SEC Filing Icon  
See Full Table

Matthew G. Manders Buying and Selling Activity at Cigna Group

This chart shows Matthew G Manders's buying and selling at Cigna Group by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cigna Group Company Overview

Cigna Group logo
The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers. The company's Cigna Healthcare segment offers medical, pharmacy, behavioral health, dental, and other products and services for insured and self-insured customers; Medicare Advantage, Medicare Supplement, and Medicare Part D plans for seniors, as well as individual health insurance plans; and health care coverage in its international markets, as well as health care benefits for mobile individuals and employees of multinational organizations. In addition, it offers permanent insurance contracts sold to corporations to provide coverage on the lives of certain employees for financing employer-paid future benefit obligations. The company distributes its products and services through insurance brokers and consultants; directly to employers, unions and other groups, or individuals; and private and public exchanges. The company was formerly known as Cigna Corporation and changed its name to The Cigna Group in February 2023. The Cigna Group was founded in 1792 and is headquartered in Bloomfield, Connecticut.
Read More

Today's Range

Now: $267.98
Low: $266.51
High: $272.09

50 Day Range

MA: $283.63
Low: $244.67
High: $311.24

2 Week Range

Now: $267.98
Low: $239.51
High: $350.00

Volume

1,551,411 shs

Average Volume

2,008,736 shs

Market Capitalization

$71.59 billion

P/E Ratio

11.82

Dividend Yield

2.23%

Beta

0.26